November 16, 2016

Morning Glance
Equity Research Desk
Indices

Value

SENSEX

Pts

Chg (%)

26304.63

(514.19)

(1.92)

NIFTY

8108.45

(187.85)

(2.26)

SGX NIFTY*

8214.00

99.00

1.22

DOW Jones

18923.06

54.37

0.29

S&P 500

2180.39

16.19

0.75

Nasdaq

5275.62

57.23

1.10

FTSE

6792.74

39.56

0.59

CAC

4536.53

27.98

0.62

DAX

10735.14

41.45

0.39

3196.99

(10.00)

(0.31)

Nikkei*

17892.50

224.35

1.27

Hang Seng*

22395.00

71.09

0.32

Strike Price

OI

Shanghai Composite*

*As at 8.30 am
Most Active Call & Put
Symbol

Chg (%)

NIFTY

8300 CE

4185525

101.97

NIFTY

8200 PE

4221150

(13.04)

Commodity

Value

Pts

NYMEX Crude (USD)

45.54

(0.27)

(0.59)

Brent Crude (USD)

46.68

(0.27)

(0.58)

Gold (INR)

29320.00

(287.00)

(0.97)

Silver (INR)

41407.00

390.00

0.95

374.65

(3.65)

(0.96)

176.50

(0.70)

(0.40)

19190.00

190.00

1.00

Copper (INR)
ZInc (INR)
Cotton (INR)

Chg (%)

Currency

Value

Pts

USD/Rupee

67.74

0.49

0.73

Euro/Rupee

72.74

0.08

0.11

Pound/Rupee

84.43

0.02

0.02

1.11

(0.01)

(0.55)

Dollar Index

97.43

0.37

0.38

Volatility

Value

Pts

CBOE VIX

13.37

(1.11)

(7.67)

India VIX

20.14

2.78

16.01

Euro /USD

Interest Rates

Value

Chg (%)

Chg (%)

6.53%

(19)

US 10-Yr Yield

2.21%

(5)

BSE

NSE

F&O

6529.98

32457.78

500299.34

Advance (Nos)

352 (13%)

119 (7%)

NA

Declines (Nos)

2360 (86%)

1453 (91%)

NA

33 (1%)

21 (1%)

NA

Turnover (INR Crs)

Unchanged

The market ended on a negative note on Tuesday. The market breadth

was negative with 6 losers for every gainer on BSE. 352 shares
advanced whereas 2360 shares declined and 33 shares were
unchanged on BSE.
BSE Sensex declined 514 points or 1.9% to close at 26305. Nifty 50 lost
188 points or 2.3% to settle at 8108. BSE Mid-Cap index declined 487
points or 3.9% to end at 11977. BSE Small-Cap index fell 583 points or
4.7% to settle at 11902.
Top gainer in BSE Sensex were SBI (1.9%), Wipro (1.5%), Dr Reddys
Labs (1.5%), ONGC (0.9%) and TCS (0.8%) whereas top loser in BSE
were Tata Motors (9.9%), Tata Steel (7.8%), Asian Paints (7.4%), Maruti
Suzuki (5.7%) and Axis Bank (3.9%).
US markets closed positive, Dow Jones Industrial Average closed at
18923, advancing 54 points (0.29%), S&P 500 advanced 16 points
(0.75%) to close at 2180 and Nasdaq advanced 57 points (1.10%) to
close at 5276.
European markets closed positive, FTSE advancing by 40 points (0.59%)
to close at 6793, CAC was up 28 points (0.62%) to close at 4537 and
DAX advanced 41 points (0.39%) to close at 10735.

Macro News

WPI inflation eased to 3.39 per cent in October from 3.57 per cent
in September as food items became cheaper. The index of food
articles group declined by 0.3 per cent due to lower price of
pulses and fruits and vegetables. CPI inflation for the month of
Otober eased to 14 month low of 4.2 per cent from 4.31 per cent
in September.

According to property consultant Colliers International, Indias

total property transaction volume over the first nine months of
2016 fell by 42% YoY to $1.40 billion, despite high level of interest
shown by institutional investors. For Q3 2016, the total
investment volume dropped by 82% to $192 million. It expects
transaction volumes to go down in real estate sector in the near
term and foresee downward pressure on prices especially in land
and secondary market transactions.

According Willis Towers Watson, salaries in India are projected to

rise 10 per cent in 2017, same as the actual increase in 2016.

Bps change

India 10-Yr Yield

Trade Statistics

Market Summary

November 16, 2016

Morning Glance
Equity Research Desk
Institutional Activity

Key News

Cash
15-Nov

Nov 2016

FIIs (INR Crs)

Buy

8958

GAIL Q2 net profit surges 180% YoY to INR 925 Cr

48103

GAIL reported nearly 180 per cent rise in net profit to INR 925 Cr for

Sell

11312

57583

Q2FY17 against INR 330 Cr reported last year. Total income from

Net

(2354)

(9481)

operations decreased 15.30 per cent YoY to INR 12058 Cr. Total

Buy

4810

35581

Sell

4915

30091

Net

(105)

5491

DII (INR Crs)

expenditure declined by 21 per cent YoY to INR 10880 Cr. Other Income
was down 38 per cent YoY to INR 317 Cr.
HPCL reported INR 701 Cr profit in Q2 on lower inventory loss
HPCL reported a profit of INR 701 Cr in Q2FY17 as against a loss of INR
317 Cr in the year-ago. The sales for the quarter increased to INR 47750

FII Derivative Statistics (NSE)

Particulars

Buy (INR Crs) Sell (INR Crs)

OI (Nos)

Chg (%)

INDEX FUTURES

3460.19

4816.53

199230

10.78

INDEX OPTIONS

78058.69

80356.35

1257380

1.89

STOCK FUTURES

10590.48

11603.15

902100

1.26

STOCK OPTIONS

10004.48

10165.63

125427

9.03

102113.83

106941.67

Total
Gainers & Losers

Cr from INR 46299 Cr a year ago. The domestic sales of petroleum

products increased to 8.02 million tonnes from 7.78 million tonnes. The
gross refining margin for the quarter rose to $3.23/barrel from
$2.74/barrel a year ago. The inventory loss in the second quarter shrank
to INR 359 Cr from INR 1406 Cr in the year-ago period.

Price

Chg (%)

Vodafone standalone service revenue up by 5.9% in first half of FY17

Gainers (INR)
SBI

278.10

1.91

Vodafone India's standalone service revenue for the first six months of

Wipro

448.05

1.51

fiscal rose by 5.9 per cent to INR 22579 Cr for 1HFY17. EBIDTA margin

3308.70

1.47

for the six months was 29.6%. Vodafone Indias enterprise solution is

275.80

0.90

growing at 2x the market rate and contributes 16.4 per cent to the

2122.10

0.81

business.

Tata Motors

457.25

(9.88)

Tata Steel

393.55

(7.80)

Nandan Denim posted a net profit of INR 16.3 Cr for Q2FY17 as against

Asian Paints

892.20

(7.41)

INR 15.61 Cr a year ago. The company's net sales stood at INR 303 Cr,

4842.70

(5.71)

up 2.75 per cent YoY. The company reported EBITDA margin of 16.23

479.15

(3.86)

per cent.

Dr Reddys Labs
ONGC
TCS
Losers (INR)

Nandan Denim Q2 net up 4%

Maruti Suzuki
Axis Bank
Sectoral Performance

Key Results Today

Value

Pts

Chg (%)

S&P BSE Small Cap

11902.01

(583.06)

(4.67)

Ramco Ind and SCI

S&P BSE Mid-Cap

11977.02

(487.00)

(3.91)

S&P BSE Auto

19520.27

(1042.41)

(5.07)

International Data

S&P BSE BANKEX

22053.32

(550.98)

(2.44)

S&P BSE Capital Goods

13923.40

(248.37)

(1.75)

S&P BSE FMCG

7973.21

(219.44)

(2.68)

15163.94

(313.14)

(2.02)

9281.65

27.42

0.30

S&P BSE Metals

10261.57

(511.17)

(4.75)

S&P Oil & Gas

11629.88

(194.72)

(1.65)

S&P BSE Healthcare

S&P BSE IT

Country

Data

US

Crude Oil Inventories

US

PPI

UK

Claimant Count Change

Forecast

Previous

NA

2.4M

0.30%

0.30%

1900

700

November 16, 2016

Morning Glance
Equity Research Desk
Sharad Avasthi

Head - Equity Research

sharad.avasthi@spagroupindia.com

Tel.: +91-33-4011 4800

Ext.832

Analyst Certification of Independence: The analyst(s) for this report certifies that all the views expressed in this report accurately reflect his or her personal views about the subject company(ies) or issuers and no part of his or her
compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts are bound by stringent internal r egulations and also legal and statutory requirements of
the Securities and Exchange Board of India (hereinafter "SEBI") and the analysts' compensation are completely delinked from all the other companies and/or entities of SPA Securities Limited, and have no bearing whatsoever on any
recommendation that they have given in the Research Report. Disclaimer and Disclosures as required under SEBI (Research Analyst) Regulations, 2014: SPA Securities Limited (hereinafter refer as SPA Securities) and its affiliates are
engaged in investment banking, investment advisory, stock broking, institutional equities, Mutual Fund Distributor and insurance broking. SPA Securities is a SEBI registered securities broking Company having membership of NSE, BSE
& MCX for Equity, Future & Option, Currency Derivatives segment and Wholesale Debt Market. The Company is focused primarily on providing securities broking services to institutional clients and is empanelled as an approved
securities broker with all the major Nationalised, Private and Co-operative banks, Corporate houses, Insurance Companies, Financial Institutions, Asset Management Companies and Provident Fund Trusts. Details of affiliates are
available on our website i.e. www.spasecurities.com.
SPA Securities Limited is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014. SEBI Reg. No. INH00002615.
We hereby declare that our activities were neither suspended nor we have defaulted with any stock exchange authority with whom we are registered in the last five years. We have not been debarred from doing business by any Stock
Exchange/SEBI or any other authorities, nor has our certificate of registration been cancelled by SEBI at any point of time.
General Disclosures: This Research Report (hereinafter called "report") has been prepared by SPA Securities and is meant for sole use by the recip ient and not for circulation. This Report does not constitute a personal
recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed
or construed to be neither advice for the purpose of purchase or sale of any security, (as defined under section 2(h) of secu rities Contracts (Regulation) Act.1956, through SPA Securities nor any solicitation or offering of any investment
/trading opportunity on behalf of the issuer(s) of the respective security (ies) referred to herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent
professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments.
This Report has been prepared on the basis of publicly available information, internally developed data and other sources bel ieved by SPA Securities to be reliable, although its accuracy and completeness cannot be guaranteed. Such
information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. Any review, retransmission or any other use is prohibited.
The information, opinions, views expressed in this Research Report are those of the research analyst as at the date of this Research Report which are subject to change and do not represent to be an authority on the subject. While we
would endeavour to update the information herein on a reasonable basis, we are under no obligation to update the information. Also, there may be regulatory, compliance or other reasons that prevent us from doing so. Hence all such
information and opinions are subject to change without notice.
Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and
investing businesses may make investment decisions that may be inconsistent with the recommendations expressed herein.
This Research Report should be read and relied upon at the sole discretion and risk of the recipient. If you are dissatisfied with the contents of this complimentary Research Report or with the terms of this Disclaimer, your sole and
exclusive remedy is to stop using this Research Report. Neither SPA Securities nor its affiliates or their respective directors, employees, agents or representatives shall be responsible or liable in any manner, directly or indirectly, for the
losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the
NAVs, reduction in the dividend or income, etc.
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. SPA Securities may have issued other reports in the past that are inconsistent with and
reach different conclusion from the information presented in this report.
SPA Securities, its affiliates and employees may, from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to
perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report.
The user should consult their own advisors to determine the merits and risks of investment and also read the Risk Disclosure Documents for Capital Markets and Derivative Segments as prescribed by Securities and Exchange Board of
India before investing in the Indian Markets.
A graph of daily closing prices of securities is available at www.nseindia.com and http://economictimes.indiatimes.com/markets/stocks/stock-quotes. (Choose a company from the list on the browser and select the "three years" icon in
the price chart).
Disclaimers in respect of jurisdiction: This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resid ent or located in any locality, state, country or other jurisdiction where such
distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject SPA Securities or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is
inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published for any purposes
without prior written approval of SPA Securities.
List of Associates as per SEBI (Research Analyst) Regulations, 2014
Statements on ownership and material conflicts of interest, compensation - SPA and Associates
Disclosure of interest statement
SPA Securities/its Affiliates/Analyst/his or her Relative financial interest in the company
SPA Securities/its Affiliates/Analyst/his or her Relative actual/beneficial ownership of more than 1% in subject company at the end of the month
Immediately preceding the date of the publication of the research report or date of public appearance.
Investment banking relationship with the company covered
Any other material conflict of interest at the time of publishing the research report
Receipt of compensation by SPA Securities or its Affiliated Companies from the subject company covered for in the last twelve months:
Managing/co-managing public offering of securities
Investment banking/merchant banking/brokerage services
products or services other than those above
in connection with research report
Whether Research Analyst has served as an officer, director or employee of the subject company covered
Whether the Research Analyst or Research Entity has been engaged in market making activity of the Subject Company;
For statements on ownership and material conflicts of interest, compensation, etc. for individual Research Analyst(s), please refer to each specific research report.

Yes/No
No
No
No
No

No

No
No

SPA Securities Ltd: Mittal Court, A-Wing, 10th Floor, Nariman Point, Mumbai - 400 021, Tel. No. : +91-022-4289 5600, Fax: +91 (22) 2657 3708/9
For More Information Visit Us At : www.spasecurities.com
SPA Securities Ltd
NSE Cash
NSE Future & Option
NSE Currency Derivatives
BSE Cash
BSE Currency Derivatives
MCX-SX Cash
MCX-SX Future & Option
MCX-SX Currency Derivatives
Mutual Fund
CDSL DP
NSDL DP
SEBI Research Analyst

SPA CAPITAL SERVICES LIMITED

Investment Advisory services,
AMFI Reg. No. ARN-0007
SPA Capital Advisors Limited
SEBI registered Category-1
Merchant Bankers
SEBI Regn. No. INM000010825
SPA COMTRADE PRIVATE LIMITED
SPA INSURANCE BROKING SERVICES LTD.
Direct Broker for Life and General
Insurance Broking
IRDA Lic. Code No. DB053/03

SEBI Reg. Nos.

INB231178238
INF231173238
INE231178238
INB011178234
INE011178234
INB261178231
INF261178231
INE261178238
ARN 77388
IN-DP-CDSL-485-2008
IN-DP-NSDL-316-2009
INH100002615